Company Filing History:
Years Active: 2005
Title: Indrajit Sanyal: Innovator in ACE-2 Modulation
Introduction
Indrajit Sanyal is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biotechnology, particularly in the modulation of ACE-2 activity. His work has implications for various diseases and disorders associated with ACE-2 expression and function.
Latest Patents
Indrajit Sanyal holds a patent titled "Methods and compositions for modulating ACE-2 activity." This patent describes binding polypeptides that specifically bind to ACE-2 protein or ACE-2-like polypeptides. These binding polypeptides can be utilized for detecting, isolating, or purifying ACE-2 protein in biological samples. The invention also encompasses nucleic acid molecules encoding these binding polypeptides, as well as methods for their production. Furthermore, it relates to methods for diagnosing and treating diseases associated with aberrant ACE-2 activity.
Career Highlights
Indrajit Sanyal is associated with Human Genome Sciences, Inc., where he has been instrumental in advancing research related to ACE-2. His innovative approaches have contributed to the understanding of ACE-2's role in various biological processes.
Collaborations
Indrajit has collaborated with notable colleagues such as Tom J Parry and Les Sekut, enhancing the research efforts in his field.
Conclusion
Indrajit Sanyal's work in modulating ACE-2 activity showcases his innovative spirit and dedication to advancing biotechnology. His contributions are vital for the development of therapeutic strategies targeting ACE-2-related diseases.